Compare PLSE & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PLSE | AVNS |
|---|---|---|
| Founded | 2014 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 521.7M |
| IPO Year | 2016 | N/A |
| Metric | PLSE | AVNS |
|---|---|---|
| Price | $15.47 | $11.52 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $22.00 | N/A |
| AVG Volume (30 Days) | 191.2K | ★ 564.1K |
| Earning Date | 11-05-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $86,000.00 | ★ $699,900,000.00 |
| Revenue This Year | N/A | $3.07 |
| Revenue Next Year | $1,002.94 | $2.16 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 2.70 |
| 52 Week Low | $12.56 | $9.30 |
| 52 Week High | $25.00 | $17.69 |
| Indicator | PLSE | AVNS |
|---|---|---|
| Relative Strength Index (RSI) | 61.80 | 47.71 |
| Support Level | $13.94 | $11.59 |
| Resistance Level | $14.70 | $12.00 |
| Average True Range (ATR) | 0.68 | 0.34 |
| MACD | 0.30 | 0.01 |
| Stochastic Oscillator | 76.83 | 41.23 |
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.